A detailed history of Barclays PLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 215,424 shares of CTKB stock, worth $926,323. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215,424
Previous 201,359 6.99%
Holding current value
$926,323
Previous $1.12 Million 25.18%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$4.7 - $7.4 $66,105 - $104,081
14,065 Added 6.99%
215,424 $1.4 Million
Q3 2024

Nov 15, 2024

BUY
$4.73 - $6.73 $732,747 - $1.04 Million
154,915 Added 333.55%
201,359 $1.12 Million
Q2 2024

Aug 14, 2024

SELL
$5.3 - $6.91 $318,922 - $415,802
-60,174 Reduced 56.44%
46,444 $259,000
Q1 2024

May 15, 2024

SELL
$6.29 - $9.15 $520,340 - $756,933
-82,725 Reduced 43.69%
106,618 $715,000
Q4 2023

Feb 15, 2024

BUY
$4.1 - $9.51 $574,672 - $1.33 Million
140,164 Added 285.01%
189,343 $1.73 Million
Q3 2023

Nov 07, 2023

BUY
$5.52 - $9.5 $2,268 - $3,904
411 Added 0.84%
49,179 $271,000
Q2 2023

Aug 03, 2023

SELL
$6.69 - $11.99 $60,350 - $108,161
-9,021 Reduced 15.61%
48,768 $416,000
Q1 2023

May 04, 2023

BUY
$8.44 - $13.47 $228,977 - $365,441
27,130 Added 88.49%
57,789 $531,000
Q4 2022

Feb 13, 2023

BUY
$9.71 - $15.86 $250,692 - $409,473
25,818 Added 533.32%
30,659 $313,000
Q3 2022

Nov 03, 2022

SELL
$10.96 - $15.45 $140,397 - $197,914
-12,810 Reduced 72.57%
4,841 $71,000
Q2 2022

Aug 12, 2022

SELL
$7.41 - $11.56 $111,187 - $173,457
-15,005 Reduced 45.95%
17,651 $189,000
Q1 2022

May 16, 2022

BUY
$9.89 - $17.25 $322,967 - $563,316
32,656 New
32,656 $351,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $579M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.